| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0005 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 0.0009 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |